Dodge & Cox’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$823M	Sell	14,561,759 -10,625	-0.1%	-$620K	0.45%	70
2025 Q4	$866M	Sell	14,572,384 -114,417	-0.8%	-$6.23M	0.47%	64
2025 Q3	$795M	Sell	14,686,801 -421,509	-3%	-$24.1M	0.43%	70
2025 Q2	$831M	Buy	15,108,310 +153,070	+1%	+$9.01M	0.47%	64
2025 Q1	$1.06B	Buy	14,955,240 +209,005	+1%	+$14.1M	0.6%	57
2024 Q4	$969M	Buy	14,746,235 +847,917	+6%	+$56.8M	0.56%	63
2024 Q3	$977M	Sell	13,898,318 -32,175	-0.2%	-$2.69M	0.55%	62
2024 Q2	$1.15B	Sell	13,930,493 -62,450	-0.4%	-$5.2M	0.69%	53
2024 Q1	$1.22B	Sell	13,992,943 -1,120	-0%	-$100K	0.71%	51
2023 Q4	$1.35B	Sell	13,994,063 -159,440	-1%	-$14.1M	0.86%	45
2023 Q3	$1.25B	Sell	14,153,503 -136,800	-1%	-$12.2M	0.84%	50
2023 Q2	$1.24B	Sell	14,290,303 -39,010	-0.3%	-$3.67M	0.83%	46
2023 Q1	$1.39B	Sell	14,329,313 -54,350	-0.4%	-$5.63M	0.95%	41
2022 Q4	$1.49B	Sell	14,383,663 -390,300	-3%	-$36.6M	1.02%	36
2022 Q3	$1.25B	Sell	14,773,963 -233,100	-2%	-$20.8M	0.95%	42
2022 Q2	$1.24B	Sell	15,007,063 -27,936	-0.2%	-$2.22M	0.86%	47
2022 Q1	$1.16B	Buy	15,034,999 +209,950	+1%	+$17.6M	0.7%	51
2021 Q4	$1.31B	Buy	14,825,049 +6,467	+0%	+$534K	0.81%	46
2021 Q3	$1.15B	Buy	14,818,582 +716,485	+5%	+$56.5M	0.75%	50
2021 Q2	$1.18B	Buy	14,102,097 +2,247,789	+19%	+$178M	0.77%	49
2021 Q1	$895M	Buy	11,854,308 +2,057,384	+21%	+$168M	0.64%	52
2020 Q4	$859M	Buy	9,796,924 +2,076,701	+27%	+$165M	0.68%	51
2020 Q3	$587M	Buy	7,720,223 +4,104,483	+114%	+$415M	0.54%	57
2020 Q2	$446M	Sell	3,615,740 -326,768	-8%	-$32.5M	0.41%	63
2020 Q1	$333M	Sell	3,942,508 -447,007	-10%	-$38.5M	0.36%	61
2019 Q4	$371M	Buy	+4,389,515	New	+$332M	0.28%	72